Author

Jingyou Yu

First Affiliated Hospital of Guangzhou Medical UniversityORCID 0000-0002-0775-6623Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Immunology· 1 Microbiology· 1 Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Research Focus:drug response / drug discovery· 1 Organism:mouse· 1 Research Focus:protein design· 1 Assay:protein sequence· 1 Assay:proteomics· 1

Frequent Co-Authors

Aiquan ChangiD· 1 shared Andrew M. BiedermanniD· 1 shared Ashley A. LemniosiD· 1 shared Brittany L. HartwelliD· 1 shared Célia Lebas· 1 shared Charles A. WhittakeriD· 1 shared Christopher A. Naranjo· 1 shared Chuanjie Zhou· 1 shared

Activity by Year

2021-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMolecular Biology

Aiquan ChangORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

MicrobiologyProceedings of the National Academy of SciencesPeer-reviewedMay 23, 2025

Autophagy-Mediated Downregulation of AXL and TIM-1 Promotes Sustained Zika Virus Infection

Jingyou Yu, Yi-Min Zheng, Megan A. Sheridan…·Shan‐Lu Liu

This study identifies ZIKV proteins that downregulate AXL and TIM-1 via autophagy, enhancing viral replication and spread by preventing superinfection and dampening innate immunity.

19 citationstop 1%

humanexperimental assay

𝕏 PostBluesky

ImmunologySignal Transduction and Targeted TherapyPeer-reviewedJul 18, 2024

Heterogeneous hybrid immunity against Omicron variant JN.1 at 11 months following breakthrough infection

Xuan He, Jiajing Jiang, Guo Li…·Weimin Li

This study evaluates hybrid immunity against the Omicron variant JN.1 11 months after breakthrough infection, showing heterogeneous responses and increased neutralization following reinfection.

5 citations

humanproteomics

𝕏 PostBluesky

Molecular BiologybioRxivPreprintMar 3, 2021

Engineered SARS-CoV-2 receptor binding domain improves immunogenicity in mice and elicits protective immunity in hamsters

Neil C. Dalvie, Sergio A. Rodriguez‐Aponte, Brittany L. Hartwell…·John Christopher Love

This paper describes an engineered SARS-CoV-2 RBD variant that shows improved immunogenicity in mice and protective immunity in hamsters.

15 citations

mouserat

𝕏 PostBluesky